Intervention to support neurodevelopment in preterm infants
Official title: Effects of a Parent-preterm Proximity and Calm Intervention (NeuroN-QI) on the Neurodevelopment of Preterm Infants: A Randomized Pragmatic Clinical Trial
Run by St. Justine's Hospital · NCT06087744 · Data updated 2026-11-12
This study tests a special program for preterm infants that includes skin-to-skin contact with parents and soothing sounds to see if it helps their brain development.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 24 Weeks to 34 Weeks |
| Sex | All |
| Enrollment | 124 (estimated) |
| Sponsor | St. Justine's Hospital Academic / other |
| Locations | 2 sites (Montreal, Quebec and 1 other locations) |
| Status | Recruiting |
| Started | November 23, 2023 |
| Main results expected | October 2026 |
| Study ends | October 2027 |
| Registry record updated | April 19, 2024 |
| Trial ID | NCT06087744 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include preterm infants born between 24 and 33 weeks of gestational age who are ready for skin-to-skin contact.
✕Probably not a fit
Patients with congenital anomalies, genetic disorders, or those requiring mechanical ventilation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
NeuroN-QI evaluates the effects of an intervention designed for preterm infants that includes skin-to-skin contact with parents and auditory stimulation through the parents' voice. The intervention also incorporates calm periods with olfactory stimulation using breast milk, all while maintaining appropriate light and noise levels. This approach aims to enhance neurodevelopmental outcomes in preterm infants by providing positive sensory experiences during their critical early weeks. The study will involve both parents and infants, particularly focusing on those born between 24 and 33 weeks of gestational age.
Why it matters
Potential benefit: If successful, this intervention could significantly improve neurodevelopmental outcomes for preterm infants.
How similar studies have gone: Other studies have shown promising results with similar interventions focusing on sensory stimulation for preterm infants.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for preterm infants: * born between 24 and 33 6/7 weeks GA; * ready for SSC Inclusion criteria for mothers and fathers: * agree to do at least one SSC session/week combined with 10 min of auditory stimulation until 36 weeks of GA of their preterm infant; * mothers express breast milk for their preterm infants For twin births (twin pregnancies), fathers will also be invited to participate in the study, so that both infants can participate in the study. Exclusion criteria for preterm infants: * congenital anomalies or genetic disorders * intraventricular hemorrhage \> grade II * are small for GA defined as birth weight \<10th percentile * on postnatal day 19 (maximum days targeted for study start) * are still receiving analgesics, sedatives, paralyzing agents * are under mechanical ventilation Exclusion criteria mothers and fathers: * are aged \<18 years; * have a physical condition that does not allow the SSC * abuse illicit substances or alcohol that could influence stress, anxiety and parent- child interactions * feed their preterm infant exclusively with commercial infant formula * mothers had a breast surgery that could influence their breast milk production * do not speak, read or write in French or in English
Where it's running
-
CHU Sainte-Justine
Montreal, Quebec, Canada Recruiting -
Cusm
Montreal, Quebec, Canada Not yet recruiting
Study contacts
- Study coordinator: Marilyn Aita, Ph.D.
- Email: marilyn.aita@umontreal.ca
- Phone: 514-343-6111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding brain development in congenital hypothyroidism: comparing affected children, healthy controls, and mild thyroid conditions
This study tests how brain development in children with congenital hypothyroidism compares to similar children without the condition and to kids with a mild thyroid finding.
-
Leopard: using multi-omics to boost genetic diagnosis for neurodevelopmental disorders
This study tests a multi-omics approach to find genetic explanations for neurodevelopmental disorders in people with moderate-to-severe intellectual disability.
-
Melillo Method for kids with behavior and learning challenges
This pilot test will see if the Melillo Method can be feasibly delivered in two Illinois schools to help kids aged 8 and up who have behavioral and learning difficulties.
-
Understanding how sensory brain signals vary in people with and without neurodevelopmental disorders
This study tests whether people with neurodevelopmental disorders show more variation in brain responses to sensory stimulation than people without these disorders.
-
Two-week intensive brain-focused therapy program for children with neurodevelopmental and chromosomal conditions
This program will try a two-week, individualized multimodal neurorehabilitation approach for children about 4–12 years old with neurodevelopmental or chromosomal conditions to see if it improves attention, motor skills, communication, and daily functioning.
-
Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development
This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.